- Home
- TSBX vs WATT Comparison
TSBX vs WATT Comparison
Compare TSBX & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- WATT
- Stock Information
- Founded
- TSBX 2015
- WATT 2012
- Country
- TSBX United States
- WATT United States
- Employees
- TSBX N/A
- WATT N/A
- Industry
- TSBX
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- TSBX
- WATT Technology
- Exchange
- TSBX Nasdaq
- WATT Nasdaq
- Market Cap
- TSBX 7.7M
- WATT 9.1M
- IPO Year
- TSBX 2023
- WATT 2014
- Fundamental
- Price
- TSBX $0.36
- WATT $0.28
- Analyst Decision
- TSBX Buy
- WATT
- Analyst Count
- TSBX 3
- WATT 0
- Target Price
- TSBX $4.75
- WATT N/A
- AVG Volume (30 Days)
- TSBX 625.8K
- WATT 2.1M
- Earning Date
- TSBX 05-08-2025
- WATT 05-13-2025
- Dividend Yield
- TSBX N/A
- WATT N/A
- EPS Growth
- TSBX N/A
- WATT N/A
- EPS
- TSBX N/A
- WATT N/A
- Revenue
- TSBX N/A
- WATT $1,047,000.00
- Revenue This Year
- TSBX N/A
- WATT $1,028.91
- Revenue Next Year
- TSBX N/A
- WATT N/A
- P/E Ratio
- TSBX N/A
- WATT N/A
- Revenue Growth
- TSBX N/A
- WATT 137.41
- 52 Week Low
- TSBX $0.29
- WATT $0.12
- 52 Week High
- TSBX $3.05
- WATT $2.70
- Technical
- Relative Strength Index (RSI)
- TSBX 56.52
- WATT 52.41
- Support Level
- TSBX $0.32
- WATT $0.27
- Resistance Level
- TSBX $0.38
- WATT $0.29
- Average True Range (ATR)
- TSBX 0.03
- WATT 0.02
- MACD
- TSBX 0.00
- WATT 0.00
- Stochastic Oscillator
- TSBX 78.89
- WATT 74.50
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.